Monday, February 1, 2021

Illumina, Sequoia Capital Launch Genomics Incubator In China

San Diego-based DNA sequencing giant Illumina, and venture capital investor Sequoia Capital---via its Sequoia Capital China arm--said they are partnering to launch a new, genomics incubator based in China. The two said the new entity, the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, will focus on building life sciences startup companies advancing breakthrough applications in genomics. The two did not say how much they are investing in the Chinese incubator. Illumina and Sequoia China said that during two six-month funding cycles per year, the genomics incubator will provide selected startups with access to investment and business guidance from Sequoia Capital China, access to Illumina sequencing systems and reagents, as well as genomics expertise, and fully operational lab space in Shanghai.

---